$2.30
-0.04-1.71%
最終更新: Oct 2, 5:17 PM
$2.30
-0.04-1.71%
Benzinga
Benzinga
Benzinga
月曜日, 10 05
Benzinga
© 2026 Benzinga | All Rights Reserved
Atossa Therapeutics (ATOS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.09 | $-1.22 | $-1.11 | $-0.35 |
| Actual | $-0.95 | $-1.11 | $-0.03 | $-0.35 |
| Surprise | +12.8% | +9.02% | +97.3% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.06 | $-1.06 | $-1.10 | $-1.10 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 7, 2026 | $-0.95 | $-1.09 | 12.8 % |
| Q1 | May 8, 2026 | $-1.11 | $-1.22 | 9.02 % |
| Q4 | Mar 25, 2026 | $-0.03 | $-1.11 | 97.3 % |
| Q3 | Nov 12, 2025 | $-0.35 | $-0.35 | 0.00 % |